ARCHIVES

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

NCI, USSR Agree On New Collaborative Cancer Control Studies

June 20, 1975

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

ASCO Begins Practice Certification Program

June 5, 2009

In Brief: NCI Study Finds No Relation Of Fluoridated Water To Cancer Incidence In U.S. Counties

December 5, 1975

Watson, Weinstein Decide FCRC Isn’t So Bad After all; DCCP to Develop RFAs, RFPs With Help Of Workshops

May 11, 1979